InflaRxs Buy Rating Reaffirmed at HC Wainwright
| IFRX Stock | USD 1.15 0.10 8.00% |
Slightly above 62% of InflaRx NV's investor base is looking to short. The analysis of the overall investor sentiment regarding InflaRx NV suggests that many traders are alarmed. InflaRx NV's investing sentiment can be driven by a variety of factors including economic data, InflaRx NV's earnings reports, geopolitical events, and overall market trends.
InflaRx |
InflaRx s stock had its buy rating restated by equities researchers at HC Wainwright in a research report issued on Thursday, Benzinga reports. They currently have a 6.00 price objective on the stock. HC Wainwrights price objective points to a potential upside of 204.57 percent from the companys previous close. InflaRx Stock Performance
Read at thelincolnianonline.com
 |
InflaRx NV Fundamental Analysis
We analyze InflaRx NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InflaRx NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InflaRx NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
InflaRx NV is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
InflaRx NV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InflaRx NV stock to make a market-neutral strategy. Peer analysis of InflaRx NV could also be used in its relative valuation, which is a method of valuing InflaRx NV by comparing valuation metrics with similar companies.
Peers
InflaRx NV Related Equities
| ABOS | Acumen Pharmaceuticals | 6.03 | ||||
| ERAS | Erasca | 4.73 | ||||
| PLX | Protalix Biotherapeutics | 4.03 | ||||
| HOWL | Werewolf Therapeutics | 3.88 | ||||
| INZY | Inozyme Pharma | 3.13 | ||||
| IKNA | Ikena Oncology | 2.31 | ||||
| ELDN | Eledon Pharmaceuticals | 1.19 | ||||
| DSGN | Design Therapeutics | 0.96 | ||||
| STOK | Stoke Therapeutics | 0.68 | ||||
| CCCC | C4 Therapeutics | 0.54 | ||||
| EWTX | Edgewise Therapeutics | 0.73 | ||||
| KZR | Kezar Life | 0.77 | ||||
| SLS | Sellas Life | 1.69 | ||||
| GBIO | Generation Bio | 2.13 | ||||
| EYPT | Eyepoint Pharmaceuticals | 2.48 | ||||
| FULC | Fulcrum Therapeutics | 2.59 | ||||
| KRON | Kronos Bio | 3.49 | ||||
| RVPH | Reviva Pharmaceuticals | 3.54 | ||||
| GLUE | Monte Rosa | 4.19 | ||||
| PASG | Passage Bio | 7.32 |
Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.